News search

The research demonstrates the benefit of a new gene silencer for treating the disease

TROPOSplice proposes an evolution-inspired strategy to improve cardiac relaxation in patients with hypertrophic cardiomyopathy and heart failure with preserved ejection fraction.

The research, presented in a Hot Line session at the European Society of Cardiology Congress in Munich and published simultaneously in The New England Journal of Medicine, proposes a paradigm shift towards prevention based on early detection through vascular imaging

The protein, OMA1, delays immune-system overactivation, liver fibrosis, and liver cancer during aging

The Foundation recognises the pioneering research into the link between gut microbiota and cardiovascular disease led by David Sancho at the CNIC 

The young Lithuanian researcher was recognised for a project on new molecular targets for the antiviral treatment of intestinal infections 

The aim of the Acércate Programme is to train the brightest young people from a very early age in order to build a pool of outstanding researchers in the field of cardiovascular research 

Hypertrophic cardiomyopathy is the most common inherited heart disease and the leading cause of sudden cardiac death in young people and athletes